美瑞新材：9月8日召开董事会会议

Group 1 - Meirui New Materials (SZ 300848) announced on September 8 that its fourth board meeting was held to discuss the proposal for capital increase in its controlling subsidiary and related transactions [1] - For the year 2024, the revenue composition of Meirui New Materials is 100.0% from the manufacturing of chemical raw materials and chemical products [1] - As of the report date, Meirui New Materials has a market capitalization of 7.1 billion yuan [1] Group 2 - The article highlights the significant growth of China's innovative pharmaceutical industry, noting a shift in trust from multinational pharmaceutical companies towards Chinese data [1]